CymitQuimica logo

CAS 2095417-00-6

:

Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
  • 5-Naphthyl-β-methylaminocarbony-3'-O-acetyl-2'-O-methl-5'-O-DMTr-uridine
    Targetmol
    + Info

    5-Naphthyl-β-methylaminocarbony-3'-O-acetyl-2'-O-methl-5'-O-DMTr-uridine

    CAS :
    Nucleoside Derivatives - 5-Modified pyrimidine nucleoside; 2’-Modified nucleoside
    Formule :C45H43N3O10
    Couleur et forme :Solid
    Masse moléculaire :785.84

    Ref: TM-TNU0635

    5mg
    À demander
    10mg
    À demander
    25mg
    À demander
    50mg
    À demander
    100mg
    À demander
    500mg
    À demander
  • 3'-O-Acetyl-5'-O-DMT-2'-O-methyl-5-naphthyl-b-methylaminocarbonyl-uridine
    Biosynth
    + Info

    3'-O-Acetyl-5'-O-DMT-2'-O-methyl-5-naphthyl-b-methylaminocarbonyl-uridine

    CAS :

    3'-O-Acetyl-5'-O-DMT-2'-O-methyl-5-naphthyl-b-methylaminocarbonyl-uridine is a modified nucleoside that has antiviral and anticancer activity. 3'-O-Acetyl-5'-O-DMT-2'-O-methyl-5-naphthyl-b -methylaminocarbonyluridine is synthesized by the direct condensation of 5-(3',4',5',6'-tetraacetyl)aminoimidazole with 2-(dimethylamino)ethanol in the presence of sodium acetate. The product is then purified by high performance liquid chromatography (HPLC). This compound has been shown to inhibit HIV replication and induce apoptosis in cancer cells.

    Degré de pureté :Min. 95%

    Ref: 3D-NA162814

    ne
    À demander